During the past decade, Cancer Care Specialists of Illinois-Swansea conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 48 clinical trials were completed, i.e. on average, 117.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 36 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Specialists of Illinois-Swansea" #1 sponsor was "SWOG Cancer Research Network" with 24 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "University of Chicago" with 12 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored and "National Cancer Institute (NCI)" with 9 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Specialists of Illinois-Swansea" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Specialists of Illinois-Swansea" are "Breast Cancer" (9 trials), "Colorectal Cancer" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Lung Cancer" (5 trials). Many other conditions were trialed in "Cancer Care Specialists of Illinois-Swansea" in a lesser frequency.

Most popular intervention types in "Cancer Care Specialists of Illinois-Swansea" are "Drug" (82 trials), "Other" (32 trials), "Biological" (14 trials), "Procedure" (8 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Placebo" (12 trials), "Quality-of-Life Assessment" (8 trials), "Questionnaire Administration" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Specialists of Illinois-Swansea" are 71 trials for "All" genders, 17 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Specialists of Illinois-Swansea". undefined are not yet recruiting, 4 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Cancer Care Specialists of Illinois-Swansea, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Specialists of Illinois-Swansea, 8 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Cancer Care Specialists of Illinois-Swansea has several departments that took part in Clinical trials: "Decatur Memorial Hospital Cancer Care Institute" - 124 trials, "Crossroads Cancer Center" - 321 trials, "Cancer Care Specialists of Illinois - Decatur" - 289 trials, "Centralia Oncology Clinic" - 249 trials, "Cancer Care Center of O'Fallon" - 188 trials, "Decatur Memorial Hospital Cancer Care Specialists of Central Illinois" - 2 trials